ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207 | -45.7% | 10,307 | -23.6% | 0.02% | -46.7% |
| Q2 2023 | $381 | +87.7% | 13,492 | +14.1% | 0.03% | +100.0% |
| Q1 2023 | $203 | -16.1% | 11,821 | -1.6% | 0.02% | -25.0% |
| Q4 2022 | $242 | -99.9% | 12,016 | -4.8% | 0.02% | -23.1% |
| Q3 2022 | $274,000 | -32.0% | 12,628 | -12.0% | 0.03% | -29.7% |
| Q2 2022 | $403,000 | +43.9% | 14,356 | +136.2% | 0.04% | +311.1% |
| Q1 2022 | $280,000 | – | 6,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |